Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flaherty

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Molecular Metabolism|May 24, 2024
Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acidsJohn D Griffin, Joanne M Buxton, Jeffrey A Culver, et al.
The American Journal of Tropical Medicine and Hygiene|June 24, 2025
Evaluation of a Scalable Design for a Pediatric Telemedicine and Medication Delivery Service: A Prospective Cohort Study in HaitiMolly B Klarman, Xiaofei Chi, Youseline Cajusma, et al.
Cancer Immunology Research|July 5, 2014
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survivalWilliam E Carson, Joseph M Unger, Jeffrey A Sosman, et al.
Plos One|October 1, 2021
High-throughput low-cost nl-qPCR for enteropathogen detection: A proof-of-concept among hospitalized patients in BangladeshKatelyn E Flaherty, Jessica A Grembi, Vasavi V Ramachandran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trialsL E Flaherty, M Atkins, J Sosman, et al.
American Journal of Clinical Oncology|December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 20, 2025
GDF15 Neutralization Ameliorates Muscle Atrophy and Exercise Intolerance in a Mouse Model of Mitochondrial MyopathyStephen E Flaherty, LouJin Song, Bina Albuquerque, et al.
BMC Health Services Research|October 22, 2025
Pathways to optimize a pediatric telemedicine and medication delivery service: a multi-level qualitative study in HaitiMolly B Klarman, Frantz Emmanuel Garilus, Kerven Cassion, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Pathways to optimize a pediatric telemedicine and medication delivery service: A multi-level qualitative study in HaitiFrantz Emmanuel Garilus, Kerven Cassion, Youseline Cajusma, et al.
Cancer|September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanomaChristopher D Lao, James Moon, Vincent T Ma, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Molecular Metabolism|May 24, 2024
Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acidsJohn D Griffin, Joanne M Buxton, Jeffrey A Culver, et al.
The American Journal of Tropical Medicine and Hygiene|June 24, 2025
Evaluation of a Scalable Design for a Pediatric Telemedicine and Medication Delivery Service: A Prospective Cohort Study in HaitiMolly B Klarman, Xiaofei Chi, Youseline Cajusma, et al.
Cancer Immunology Research|July 5, 2014
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survivalWilliam E Carson, Joseph M Unger, Jeffrey A Sosman, et al.
Plos One|October 1, 2021
High-throughput low-cost nl-qPCR for enteropathogen detection: A proof-of-concept among hospitalized patients in BangladeshKatelyn E Flaherty, Jessica A Grembi, Vasavi V Ramachandran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trialsL E Flaherty, M Atkins, J Sosman, et al.
American Journal of Clinical Oncology|December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 20, 2025
GDF15 Neutralization Ameliorates Muscle Atrophy and Exercise Intolerance in a Mouse Model of Mitochondrial MyopathyStephen E Flaherty, LouJin Song, Bina Albuquerque, et al.
BMC Health Services Research|October 22, 2025
Pathways to optimize a pediatric telemedicine and medication delivery service: a multi-level qualitative study in HaitiMolly B Klarman, Frantz Emmanuel Garilus, Kerven Cassion, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Pathways to optimize a pediatric telemedicine and medication delivery service: A multi-level qualitative study in HaitiFrantz Emmanuel Garilus, Kerven Cassion, Youseline Cajusma, et al.
Cancer|September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanomaChristopher D Lao, James Moon, Vincent T Ma, et al.
Pageof 13